Vertex Pharmaceuticals Inc. buy Guggenheim
Start price
06.08.25
/
50%
€329.95
Target price
06.08.26
€471.96
Performance (%)
-1.85%
Price
17:49
€323.85
Summary
This prediction is currently active. With a performance of -1.85%, the BUY prediction by Guggenheim is trending in the wrong direction. This prediction currently runs until 06.08.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Vertex Pharmaceuticals Inc. | -1.85% |
| iShares Core DAX® | -0.933% |
| iShares Nasdaq 100 | -2.152% |
| iShares Nikkei 225® | 0.021% |
| iShares S&P 500 | -2.296% |
Comments by Guggenheim for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) had its price target lowered by analysts at Guggenheim from $558.00 to $546.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Guggenheim for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€453.20
02.08.24
02.08.24
€511.18
02.08.25
02.08.25
-11.90%
03.08.25
03.08.25
